SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000947871-11-000646
Filing Date
2011-07-07
Accepted
2011-07-07 14:14:34
Documents
1
Group Members
ADAM L. USDANTRELLUS OFFSHORE FUND LIMITEDTRELLUS PARTNERS II, L.P.TRELLUS PARTNERS L.P.

Document Format Files

Seq Description Document Type Size
1 AMENDMENT TO SCHEDULE 13G ss122686_sc13ga-elite.htm SC 13G/A 189183
  Complete submission text file 0000947871-11-000646.txt   190792
Mailing Address 165 LUDLOW AVENUE NORTHVALE NJ 07647
Business Address 165 LUDLOW AVENUE NORTHVALE NJ 07647 2017502646
ELITE PHARMACEUTICALS INC /DE/ (Subject) CIK: 0001053369 (see all company filings)

IRS No.: 223542636 | State of Incorp.: DE | Fiscal Year End: 0331
Type: SC 13G/A | Act: 34 | File No.: 005-59693 | Film No.: 11955932
SIC: 2834 Pharmaceutical Preparations

Mailing Address 350 MADISON AVENUE - 9TH FL NEW YORK NY 10017
Business Address 350 MADISON AVENUE - 9TH FL NEW YORK NY 10017 212-389-8799
Trellus Management Company, LLC (Filed by) CIK: 0001307877 (see all company filings)

IRS No.: 133807183 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A